1-9 of 9
Marc G. Jacquemin
Close
Sort by
Journal Articles

Immune Tolerance Induction by High Doses FVIII in Hemophilia A Patients with Inhibitor Does Not Require Deletion of FVIII-Specific T Cells.

Marc G. Jacquemin, MD, Renaud Lavend’homme, Ms, Thérèse Tinot, Ms, Kathelijne Peerlinck, MD, Jean Marie Saint-Remy, MD, Brigitte Pautard, MD
Journal: Blood
Blood (2006) 108 (11): 1029.
https://doi.org/10.1182/blood.V108.11.1029.1029
Published: 2006
Journal Articles

A Limited Number of Anti-Idiotypic Antibodies Is Required To Maintain FVIII Function in Presence of Polyclonal Anti-FVIII Antibodies of Haemophilia A Patients with Inhibitors.

Jean Guy G. Gilles, PhD, Sabrina E. Grailly, MSc, Marc G. Jacquemin, MD, Jean Marie M. Saint-Remy, MD
Journal: Blood
Blood (2006) 108 (11): 1004.
https://doi.org/10.1182/blood.V108.11.1004.1004
Published: 2006
Journal Articles

The Determination of the Inhibitory Activity of Some Factor VIII Type II Inhibitor Antibodies Is Biased by the Type of Factor VIII Assay.

Marc G. Jacquemin, MD, Seb Lamprecht, MSc, Renaud Lavend’homme, MSc, Jan Roodt, MSc, Bernard Chatelain, MD, Veronique Deneys, MD, Jeroen Dewaele, MSc, Jean-Marie Stassen, PhD, Muriel Meiring, PhD, Jean Marie Saint-Remy, MD, Henry Pieters, PhD, Philip Badenhorst, MD
Journal: Blood
Blood (2005) 106 (11): 3200.
https://doi.org/10.1182/blood.V106.11.3200.3200
Published: 2005
Journal Articles

Tolerance induction: a job for B cells?

Jean-Marie R. Saint-Remy, Marc G. Jacquemin
Journal: Blood
Blood (2005) 105 (12): 4551.
https://doi.org/10.1182/blood-2005-03-1229
Published: 2005
Journal Articles

Rupture of T Cell Tolerance to Self Factor VIII in Mild/Moderate Hemophilia A.

Marc G. Jacquemin, MD, PhD, Renaud Lavend’homme, Ms, Benhida Abdellah, Kathelijne Peerlinck, MD, PhD, Jos Vermylen, MD, PhD, Véronique Deneys, MD, PhD, Jean-Marie Saint-Remy, MD, PhD, Cédric Hermans, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3076.
https://doi.org/10.1182/blood.V104.11.3076.3076
Published: 2004
Journal Articles

In vivo neutralization of a C2 domain–specific human anti–Factor VIII inhibitor by an anti-idiotypic antibody

Jean Guy G. Gilles, Sabrina C. Grailly, Marc De Maeyer, Marc G. Jacquemin, Luc P. VanderElst, Jean-Marie R. Saint-Remy
Journal: Blood
Blood (2004) 103 (7): 2617–2623.
https://doi.org/10.1182/blood-2003-07-2207
Published: 2004
Journal Articles

Antigenicity of putative phospholipid membrane-binding residues in factor VIII

Rachel T. Barrow, John F. Healey, Marc G. Jacquemin, Jean-Marie R. Saint-Remy, Pete Lollar
Journal: Blood
Blood (2001) 97 (1): 169–174.
https://doi.org/10.1182/blood.V97.1.169
Published: 2001
Journal Articles

Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A

Kathelijne Peerlinck, Marc G. Jacquemin, Jef Arnout, Marc F. Hoylaerts, Jean Guy G. Gilles, Renaud Lavend’homme, Karen M. Johnson, Kathleen Freson, Dorothea Scandella, Jean-Marie R. Saint-Remy, Jos Vermylen
Journal: Blood
Blood (1999) 93 (7): 2267–2273.
https://doi.org/10.1182/blood.V93.7.2267
Published: 1999
Journal Articles

Mechanism and Kinetics of Factor VIII Inactivation: Study With an IgG4 Monoclonal Antibody Derived From a Hemophilia A Patient With Inhibitor

Marc G. Jacquemin, Benoı̂t G. Desqueper, Abdellah Benhida, Luc Vander Elst, Marc F. Hoylaerts, Marleen Bakkus, Kris Thielemans, Jef Arnout, Kathelijne Peerlinck, Jean Guy G. Gilles, Jos Vermylen, Jean-Marie R. Saint-Remy
Journal: Blood
Blood (1998) 92 (2): 496–506.
https://doi.org/10.1182/blood.V92.2.496
Published: 1998